We are live on ! Find out more
CS

Cannell & Spears Portfolio holdings

AUM $5.1B
1-Year Est. Return 31.77%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+31.77%
3 Year Est. Return
+94.5%
5 Year Est. Return
+108.17%
10 Year Est. Return
+357.88%
AUM
$795M
AUM Growth
+$6.19M
Cap. Flow
-$32.6M
Cap. Flow %
-4.11%
Top 10 Hldgs %
46.46%
Holding
136
New
12
Increased
7
Reduced
57
Closed
9

Top Buys

Rank Stock Value
1
BALL icon
Ball Corp
BALL
+$20.6M
2
FTV icon
Fortive
FTV
+$9.55M
3
GILD icon
Gilead Sciences
GILD
+$6.89M
4
BMY icon
Bristol-Myers Squibb
BMY
+$606K
5
GS icon
Goldman Sachs
GS
+$575K

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$12M
2
KMI icon
Kinder Morgan
KMI
+$8.39M
3
CB icon
Chubb
CB
+$5.05M
4
CIT
CIT Group Inc.
CIT
+$3.81M
5
JCI icon
Johnson Controls International
JCI
+$3.65M

Sector Composition

Rank Sector Weight
1 Financials 25.93%
2 Healthcare 20.54%
3 Technology 14.4%
4 Industrials 13.46%
5 Consumer Discretionary 9.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTV icon
26
Fortive
FTV
$19B
$9.55M 1.2%
+297,434
New +$9.55M
JNJ icon
27
Johnson & Johnson
JNJ
$635B
$5.78M 0.73%
48,931
-800
-2% -$97.1K
AXS icon
28
AXIS Capital
AXS
$8.59B
$4.08M 0.51%
75,071
-1,958
-3% -$108K
UNH icon
29
UnitedHealth
UNH
$382B
$2.87M 0.36%
20,531
SPY icon
30
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$2.79M 0.35%
12,907
XOM icon
31
ExxonMobil
XOM
$651B
$2.76M 0.35%
31,632
-550
-2% -$48.8K
VEA icon
32
Vanguard FTSE Developed Markets ETF
VEA
$226B
$2.36M 0.3%
63,094
-24,670
-28% -$907K
BIIB icon
33
Biogen
BIIB
$29.9B
$2.27M 0.29%
7,241
UNB icon
34
Union Bankshares
UNB
$114M
$2.12M 0.27%
62,160
CVS icon
35
CVS Health
CVS
$137B
$2.1M 0.26%
23,560
-600
-2% -$56.6K
AON icon
36
Aon
AON
$77.3B
$2.09M 0.26%
18,541
-4,000
-18% -$441K
KMI icon
37
Kinder Morgan
KMI
$73.1B
$2.06M 0.26%
88,990
-396,046
-82% -$8.39M
PG icon
38
Procter & Gamble
PG
$343B
$1.86M 0.23%
20,698
-530
-2% -$46K
BRK.B icon
39
Berkshire Hathaway Class B
BRK.B
$1.07T
$1.82M 0.23%
12,616
-860
-6% -$126K
DFE icon
40
WisdomTree Europe SmallCap Dividend Fund
DFE
$163M
$1.72M 0.22%
31,170
-12,810
-29% -$690K
MRK icon
41
Merck
MRK
$324B
$1.58M 0.2%
26,531
WFC icon
42
Wells Fargo
WFC
$261B
$1.51M 0.19%
34,224
-23,565
-41% -$1.13M
TRMB icon
43
Trimble
TRMB
$12.3B
$1.49M 0.19%
52,000
SYK icon
44
Stryker
SYK
$127B
$1.35M 0.17%
11,600
-510
-4% -$59.4K
MKL icon
45
Markel Group
MKL
$25B
$1.32M 0.17%
1,423
XLY icon
46
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.4B
$1.16M 0.15%
28,930
-200
-0.7% -$8.06K
CCI icon
47
Crown Castle
CCI
$32.7B
$1.1M 0.14%
11,725
SBUX icon
48
Starbucks
SBUX
$118B
$1.08M 0.14%
20,049
BRK.A icon
49
Berkshire Hathaway Class A
BRK.A
$1.07T
$1.08M 0.14%
5
MMM icon
50
3M
MMM
$89B
$1.06M 0.13%
7,229
-833
-10% -$124K

Similar funds

Cannell & Spears's Q3 2016 Portfolio in Review

As of Q3 2016, Cannell & Spears held 136 positions worth $795M, up 0.79% from $789M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Cannell & Spears withdrew a net $32.6M in Q3 2016, closing 9 positions and reducing 57 holdings. Its most notable exit was Columbia Emerging Markets Consumer ETF, an estimated $525K position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Cannell & Spears opened a new position in Ball Corp worth $22.1M.

  • Cannell & Spears's largest Q3 2016 buy was Ball Corp: 538,890 shares worth $22.1M.
  • Cannell & Spears added most to Gilead Sciences in Q3 2016, an estimated $6.89M increase.
  • Cannell & Spears's biggest Q3 2016 reduction was Danaher, cutting an estimated $12M.
  • Cannell & Spears fully exited Columbia Emerging Markets Consumer ETF in Q3 2016, selling an estimated $525K.
  • Cannell & Spears's ten largest holdings make up 46% of its $795M portfolio in Q3 2016.
  • Cannell & Spears opened 12 new positions and closed 9 in Q3 2016.
  • Cannell & Spears's portfolio value rose 0.79% quarter-over-quarter to $795M.

Based on Cannell & Spears's 13F filing for Q3 2016, filed 14 Nov 2016.